U.S. medtech shares gain as investors seek shelter from drug price debate
March 13, 2017 at 16:36 PM EDT
NEW YORK, March 13 (Reuters) - Investors are seeking shelter in shares of U.S. medical device and supply companies, encouraged by their solid growth prospects and wary that U.S. President Donald Trump's criticism of drug prices makes owning pharmaceutical and biotechnology stocks risky.